InvestLog
ROIV logo

ROIV

Roivant Sciences Ltd.NASDAQHealthcare
$28.33+1.76%ClosedMarket Cap: $20.28B

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

13

Sales

47

Buy/Sell Ratio

0.28

Total Bought

$0.00

Total Sold

$24.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 02Torti Frankofficer: President and Vant ChairSell160,035$27.7013,576,512
Wed Apr 01Gline Matthewdirector, officer: CEOSell97,319$12.6817,384,400
Wed Apr 01Sukhatme Mayukhdirector, officer: President & CIOSell1,306,889$0.000
Wed Apr 01Sukhatme Mayukhdirector, officer: President & CIOSell187,512$27.7018,677,617
Wed Apr 01Sukhatme Mayukhdirector, officer: President & CIOSell29,809$26.4118,865,129
Wed Apr 01Sukhatme Mayukhdirector, officer: President & CIOSell58,391$12.6818,894,938
Wed Apr 01Gline Matthewdirector, officer: CEOSell2,178,150$0.000
Wed Apr 01Gline Matthewdirector, officer: CEOSell304,684$27.7017,025,890
Wed Apr 01Gline Matthewdirector, officer: CEOSell53,826$26.4117,330,574
Mon Mar 30Fitzgerald MeghandirectorSell70,000$27.4542,963
Mon Mar 30Fitzgerald MeghandirectorSell70,000$8.80112,963
Tue Mar 24Pulik Richardofficer: CFOSell1,546$27.70236,867
Tue Mar 24Humes Jenniferofficer: Chief Accounting OfficerSell14,526$27.7097,729
Thu Mar 19Venker Ericofficer: President & Immunovant CEOSell200,000$28.241,647,546
Thu Mar 19Venker Ericofficer: President & Immunovant CEOSell200,000$3.854,844,834